Analystreport

Dermira Inc (NASDAQ: DERM) had its price target raised by analysts at Leerink Swann from $42.00 to $48.00. They now have an "outperform" rating on the stock.

Journey Medical Corporation  (DERM) 
Last journey medical corporation earnings: 11/5 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.dermira.com